Cargando…

Treatment‐related adverse events of antibody–drug conjugates in clinical trials: A systematic review and meta‐analysis

BACKGROUND: Antibody–drug conjugates (ADCs) have complex molecular structures and have been tested in numerous clinical trials. Therefore, understanding the mechanisms of their toxicity when applied in medical practice is of high importance. METHODS: In a systematic review and meta‐analysis of data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Youwen, Liu, Kun, Wang, Kailing, Zhu, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099922/ https://www.ncbi.nlm.nih.gov/pubmed/36408673 http://dx.doi.org/10.1002/cncr.34507

Ejemplares similares

Treatment-related adverse events associated with HER2-Targeted antibody-drug conjugates in clinical trials: a systematic review and meta-analysis
por: Fu, Zhiwen, et al.
Publicado: (2022)

Adverse events of antibody–drug conjugates on the ocular surface in cancer therapy
por: Domínguez-Llamas, Sandra, et al.
Publicado: (2023)

Vascular Endothelial Growth Factor Receptor Inhibitors in Chinese Patients With Advanced Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Network Meta-Analysis and Cost-Effectiveness Analysis
por: Zhu, Youwen, et al.
Publicado: (2022)

Adverse Events for Monoclonal Antibodies in Patients with Allergic Rhinitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Lin, Yuxi, et al.
Publicado: (2023)

Incidence and risk of fatal adverse events in cancer patients treated with HER2-targeted antibody-drug conjugates: a systematic review and meta-analysis of randomized controlled trials
por: Fu, Zhiwen, et al.
Publicado: (2023)

Trastuzumab deruxtecan versus trastuzumab emtansine for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A cost-effectiveness analysis
por: Zhu, Youwen, et al.
Publicado: (2022)

Chemo-Immunotherapy Regimes for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Network Meta-Analysis and Cost-Effectiveness Analysis
por: Zhu, Youwen, et al.
Publicado: (2022)

Antibody-drug conjugates: the clinical development in gastric cancer
por: Zhu, Yingze, et al.
Publicado: (2023)

Data reproducibility issues on evidence synthesis of adverse events associated with HER2-targeted antibody–drug conjugates
por: Wu, Dan-Na, et al.
Publicado: (2023)

Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
por: Bertrand, Anne, et al.
Publicado: (2015)

Efficacy and Treatment-Related Adverse Events of Romidepsin in PTCL Clinical Studies: A Systematic Review and Meta-Analysis
por: Du, Jun, et al.
Publicado: (2021)

Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
por: Su, Eric Wen, et al.
Publicado: (2017)

Quality of reporting of adverse events in clinical trials of covid-19 drugs: systematic review
por: Madi, Karima, et al.
Publicado: (2023)

A Systematic Review and Meta-Analysis of Immune-Related Adverse Events of Anti-PD-1 Drugs in Randomized Controlled Trials
por: Wang, Yukun, et al.
Publicado: (2020)

Acupuncture-related adverse events: systematic review and meta-analyses of prospective clinical studies
por: Bäumler, Petra, et al.
Publicado: (2021)

Clinical Pharmacology of Antibody-Drug Conjugates
por: Mahmood, Iftekhar
Publicado: (2021)

Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events
por: Yu, Yue, et al.
Publicado: (2016)

Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
por: Yu, Bo, et al.
Publicado: (2019)

Which Adverse Events and Which Drugs Are Implicated in Drug-Related Hospital Admissions? A Systematic Review and Meta-Analysis
por: Haerdtlein, Annette, et al.
Publicado: (2023)

Treatment-Related Adverse Events of Chimeric Antigen Receptor T-Cell (CAR T) in Clinical Trials: A Systematic Review and Meta-Analysis
por: Lei, Wen, et al.
Publicado: (2021)

Exploration of the antibody–drug conjugate clinical landscape
por: Maecker, Heather, et al.
Publicado: (2023)

Effects of Acupuncture on Adverse Events in Colonoscopy: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Wang, Jing, et al.
Publicado: (2022)

Correction to: Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
por: Yu, Bo, et al.
Publicado: (2020)

Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
por: Dugal-Tessier, Julien, et al.
Publicado: (2021)

Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates
por: Donaghy, Heather
Publicado: (2016)

A systematic review of adult admissions to ICUs related to adverse drug events
por: Jolivot, Pierre-Alain, et al.
Publicado: (2014)

Clinical trial update on bispecific antibodies, antibody-drug conjugates, and antibody-containing regimens for acute lymphoblastic leukemia
por: Liu, Delong, et al.
Publicado: (2019)

Incidence of Placebo Adverse Events in Randomized Clinical Trials of Targeted and Immunotherapy Cancer Drugs in the Adjuvant Setting: A Systematic Review and Meta-analysis
por: Chacón, Matías Rodrigo, et al.
Publicado: (2018)

Toxicity profiles of antibody-drug conjugates for anticancer treatment: a systematic review and meta-analysis
por: Suzuki, Yukio, et al.
Publicado: (2023)

The Adverse Events of Oxycodone in Cancer-Related Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ma, Hu, et al.
Publicado: (2016)

Comparative efficacy and safety of novel immuno-chemotherapy for extensive-stage small-cell lung cancer: a network meta-analysis of randomized controlled trial
por: Zhu, Youwen, et al.
Publicado: (2023)

Challenges in Coding Adverse Events in Clinical Trials: A Systematic Review
por: Schroll, Jeppe Bennekou, et al.
Publicado: (2012)

Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice
por: Janthur, Wolf-Dieter, et al.
Publicado: (2012)

Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events
por: Roitmann, Eva, et al.
Publicado: (2014)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
por: Han, Nayoung, et al.
Publicado: (2021)

Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy
por: Underwood, Jonathan, et al.
Publicado: (2019)

Immunotherapy or targeted therapy as the first-line strategies for unresectable hepatocellular carcinoma: A network meta-analysis and cost-effectiveness analysis
por: Liu, Kun, et al.
Publicado: (2023)

Conjugates of Small Molecule Drugs with Antibodies and Other Proteins
por: Feng, Yang, et al.
Publicado: (2014)

Big Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials
por: Federer, Callie, et al.
Publicado: (2016)

Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review
por: Ouyang, Tao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c14gs7cpmgfj0fjek5cmdnl9b3